Rotate your device

Please rotate your device to landscape mode
for the best experience.

AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Krypton Erlotinib 150mg Tablet

Prescription Icon
Prescription Required

Marketer

Krypton Global Health

Salt Composition

Erlotinib (150mg)

Overview Krypton Erlotinib 150mg Tablet

Erlotinib 150mg tablets (Krypton brand) treat non-small cell lung and pancreatic cancers. Administer this medication on an empty stomach, or one hour before or two hours after eating. Continue treatment as directed by your physician; duration depends on individual response. Follow your doctor's instructions precisely; incorrect usage or overdose can cause severe adverse effects. Benefits may take weeks or months to appear; do not discontinue without your doctor's consent. Common side effects include nausea, vomiting, tiredness, skin rash, and weight loss. Severe diarrhea requires increased fluid intake or medical attention. Photosensitivity is a potential side effect; wear protective clothing and sunscreen outdoors. Report mouth sores, vision changes, or breathing problems to your physician immediately. Regular liver function monitoring may be necessary. Inform your healthcare provider of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy or breastfeeding; effective contraception is crucial for both partners. Smoking cessation is advised, as it can interfere with treatment efficacy. Maintain a two-hour interval between this medication and antacids or other drugs.

Primary Ingredients of Krypton Erlotinib 150mg Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Krypton Erlotinib 150mg Tablet

Cancers of the pancreas and non-small-cell lung

Major Benefits of Krypton Erlotinib 150mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Krypton Erlotinib 150mg tablets should be taken on an empty stomach.

Common Side effects of Krypton Erlotinib 150mg Tablet:

  • Abdominal pain
  • Bone pain
  • Breathlessness
  • Constipation
  • Cough
  • Diarrhea
  • Fatigue
  • Fever
  • Infection
  • Muscle pain
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Vomiting
  • Weight loss

How to use Krypton Erlotinib 150mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Krypton Erlotinib 150mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.

How Krypton Erlotinib 150mg Tablet works:

Erlotinib 150mg tablets (Krypton brand) are an anti-neoplastic agent. Lung cancer cells possess epidermal growth factor receptors (EGFRs) which regulate their proliferation. The drug functions by attaching to EGFR, thereby blocking the cancer-promoting signals transmitted through these receptors and halting further tumor development.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Krypton Erlotinib 150mg Tablets lacks established safety data. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Erlotinib 150mg tablets (Krypton brand) pose a confirmed risk to a fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Erlotinib 150mg tablets (Krypton brand) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Krypton Erlotinib 150mg Tablet on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Erlotinib 150mg tablets (Krypton) are considered safe for individuals with kidney impairment; no dosage modification is necessary. However, administration is not recommended for patients experiencing severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Erlotinib 150mg tablets cautiously. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Krypton Erlotinib 150mg Tablet :

Omit any missed Krypton Erlotinib 150mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Krypton Erlotinib 150mg Tablet

LabelValue
Chemical Classification Quinazoline-based compound
Developing Habits No.
Treatment Category Cancer Medications
Krypton Erlotinib 150mg T...
10,368
MRP 12,000
13% off
Mobile Banner